# A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy Volunteers

> **NCT01891851** · PHASE1 · COMPLETED · sponsor: **Tibotec Pharmaceuticals, Ireland** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TMC435350 200 mg
- **DRUG:** Ritonavir 100 mg

## Key facts

- **NCT ID:** NCT01891851
- **Lead sponsor:** Tibotec Pharmaceuticals, Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891851, "A Study of Drug-drug Interaction Between Ritonavir and TMC435350 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01891851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*